Sign In
Buy FTXH
$34.53
+0.573 (+1.69%)
At Close: Jun 03, 2026
Trump to announce discount drug pricing expansion, White House official says
12:47pm, Monday, 18'th May 2026
U.S. President Donald Trump will announce a dramatic expansion of TrumpRx.gov, a government-backed website offering discounted prescription drugs under his administration's pricing deal, on Mond
Could pressure to make money faster kill the next lifesaving pill?
11:27am, Wednesday, 15'th Apr 2026
When activist investors take a stake in a pharmaceutical company, markets often cheer. The expectation is leaner operations, sharper strategy and higher stock prices.
Pharma ETF (FTXH) Hits New 52-Week High
07:01am, Wednesday, 19'th Nov 2025
Pharma ETF FTXH hits a new 52-week high as industry momentum, rate cuts, and AI adoption lift the sector???signaling potential near-term upside for FTXH investors.
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
01:22pm, Friday, 26'th Sep 2025
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
10:26am, Friday, 26'th Sep 2025
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
A Look at Pharma ETFs After Strong Q1 Earnings
12:50pm, Thursday, 08'th May 2025
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Pharma ETFs in Focus Post Solid Q2 Earnings
12:51pm, Wednesday, 14'th Aug 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
A Look at Pharma ETFs Post Q1 Earnings
12:31pm, Tuesday, 07'th May 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
11:00am, Wednesday, 17'th Apr 2024
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
A Look at Pharma ETFs After Q4 Earnings
02:01pm, Monday, 12'th Feb 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs re
Pharma ETFs in Focus Post Q3 Earnings
12:46pm, Wednesday, 08'th Nov 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
5 ETFs to Buy on JNJ's Q2 Earnings Strength
11:27am, Friday, 21'st Jul 2023
Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
Pharma ETFs Gain Post Q1 Earnings
01:01pm, Tuesday, 09'th May 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.
